OTCMKTS:LZAGY

Lonza Group Stock Forecast, Price & News

$61.03
-0.13 (-0.21 %)
(As of 04/16/2021 12:00 AM ET)
Add
Compare
Today's Range
$60.22
Now: $61.03
$61.09
50-Day Range
$55.69
MA: $59.14
$63.98
52-Week Range
$41.68
Now: $61.03
$69.07
Volume231,044 shs
Average Volume94,966 shs
Market Capitalization$45.45 billion
P/E Ratio44.55
Dividend Yield0.35%
Beta0.7
Lonza Group Ltd supplies products and services to the pharmaceutical, biotech, and specialty ingredients markets worldwide. The company operates through two segments, Pharma Biotech & Nutrition, and Specialty Ingredients. The Pharma Biotech & Nutrition segment provides technology platforms, including drug substance and drug product; and develops and manufactures customized active pharmaceutical ingredients and biopharmaceuticals, as well as formulation services and delivery systems for pharmaceutical and nutritional applications. It serves pharmaceutical companies, biotechnology firms, and medical research and testing organizations, as well as consumer health and nutrition companies. The Specialty Ingredients segment operates microbial control solutions and specialty chemical services businesses. Its Microbial control solutions business has offerings in professional hygiene, and home and personal care markets; and offerings in paints and coating, wood protection, material protection, and crop protection. This segments also offers specialty chemicals in electronics, aerospace, food and feed ingredients, agro chemicals, and diversified specialty chemicals markets. The company has collaboration with Moderna, Inc. to manufacture a potential COVID-19 vaccine, mRNA-1273; and an agreement with Capricor Therapeutics, Inc. for the development of CAP-1002, a clinical asset for the treatment of Duchenne Muscular Dystrophy and complications arising from COVID-19. Lonza Group Ltd was founded in 1897 and is headquartered in Basel, Switzerland.
Lonza Group logo

Industry, Sector and Symbol

Industry Tobacco products
Sub-IndustryN/A
SectorMedical
Current SymbolOTCMKTS:LZAGY
CUSIPN/A
CIKN/A
Phone41-61-316-8111
Employees14,000
Year Founded1897

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$978.37 million
Cash Flow$1.22 per share
Book Value$8.87 per share

Profitability

Miscellaneous

Market Cap$45.45 billion
Next Earnings DateN/A
OptionableNot Optionable

Headlines

Lonza Group Ltd (OTCMKTS:LZAGY) Short Interest Update
March 31, 2021 |  americanbankingnews.com
Lonza Group AG to Host Earnings Call
January 27, 2021 |  finance.yahoo.com
Lonza Group AG ADR
January 24, 2021 |  wsj.com
Moderna Vaccine Production Is Gearing Up, Partner Lonza Says
November 19, 2020 |  finance.yahoo.com
Lonza Group Ltd (LZAGY)
October 23, 2020 |  finance.yahoo.com
See More Headlines

MarketRank

Overall MarketRank

1.06 out of 5 stars

Medical Sector

1021st out of 2,025 stocks

Tobacco Products Industry

4th out of 8 stocks

Analyst Opinion: 0.0Community Rank: 2.4Dividend Strength: 1.7Insider Behavior: 0.0Valuation: 1.3 5 -4 -3 -2 -1 -
$61.03
-0.13 (-0.21 %)
(As of 04/16/2021 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive LZAGY News and Ratings via Email

Sign-up to receive the latest news and ratings for LZAGY and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Lonza Group (OTCMKTS:LZAGY) Frequently Asked Questions

Is Lonza Group a buy right now?

9 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Lonza Group in the last year. There are currently 2 hold ratings and 7 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" Lonza Group stock.
View analyst ratings for Lonza Group
or view top-rated stocks.

What stocks does MarketBeat like better than Lonza Group?

Wall Street analysts have given Lonza Group a "Buy" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Lonza Group wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

Are investors shorting Lonza Group?

Lonza Group saw a decline in short interest during the month of March. As of March 31st, there was short interest totaling 7,100 shares, a decline of 59.0% from the March 15th total of 17,300 shares. Based on an average daily trading volume, of 117,200 shares, the short-interest ratio is presently 0.1 days.
View Lonza Group's Short Interest
.

How has Lonza Group's stock price been impacted by COVID-19 (Coronavirus)?

Lonza Group's stock was trading at $38.43 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization (WHO). Since then, LZAGY stock has increased by 58.8% and is now trading at $61.03.
View which stocks have been most impacted by COVID-19
.

Is Lonza Group a good dividend stock?

Lonza Group pays an annual dividend of $0.21 per share and currently has a dividend yield of 0.35%. The dividend payout ratio of Lonza Group is 15.33%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, Lonza Group will have a dividend payout ratio of 14.00% next year. This indicates that Lonza Group will be able to sustain or increase its dividend.
View Lonza Group's dividend history.

Who are Lonza Group's key executives?

Lonza Group's management team includes the following people:
  • Dr. Pierre-Alain Ruffieux, Chief Exec. Officer (Age 51) (LinkedIn Profile)
  • Mr. Rodolfo J. Savitzky, Chief Financial Officer (Age 59)
  • Mr. Dirk Oehlers, VP of Investor Relations
  • Victoria Morgan, Head of Corp. Communications
  • Mr. Joseph R. Colleluori, Sr. VP of Corp. Devel.
  • Ms. Jennifer Clancy, Sr. Director of Global Marketing
  • Ms. Caroline Barth, Chief HR Officer (LinkedIn Profile)
  • Ms. Constance Ward, Head of External Communications
  • Mr. Stefan Stoffel, Chief Operating Officer of Lonza Pharma Biotech & Nutrition (Age 55) (LinkedIn Profile)
  • Dr. Sanna Fowler, Head of External Communications

Who are some of Lonza Group's key competitors?

What is Lonza Group's stock symbol?

Lonza Group trades on the OTCMKTS under the ticker symbol "LZAGY."

How do I buy shares of Lonza Group?

Shares of LZAGY can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Lonza Group's stock price today?

One share of LZAGY stock can currently be purchased for approximately $61.03.

How much money does Lonza Group make?

Lonza Group has a market capitalization of $45.45 billion and generates $978.37 million in revenue each year. The company earns $649.19 million in net income (profit) each year or $1.37 on an earnings per share basis.

How many employees does Lonza Group have?

Lonza Group employs 14,000 workers across the globe.

Does Lonza Group have any subsidiaries?

The following companies are subsidiares of Lonza Group: Arch Acquisition LLC, Arch Chemicals Canada Inc., Arch Chemicals Inc., Arch Chemicals Limited, Arch Chemicals Receivables LLC, Arch Chemicals SAS, Arch Personal Care Products L.P., Arch Protection Chemicals Private Limited, Arch Quimica Argentina S.R.L., Arch Quimica Brasil Ltda., Arch Timber Protection B.V., Arch Treatment Technologies Inc., Arch UK Biocides Limited, Arch Water Products France S.A.S., Arch Water Products South Africa (Pty) Ltd, Arch Wood Protection (Aust) Pty Ltd, Arch Wood Protection (M) Sdn. Bhd., Arch Wood Protection (NZ) Limited, Arch Wood Protection (SA) Pty Ltd, Arch Wood Protection Canada Corp., Arch Wood Protection Inc, Bend Research Inc., BioAtrium AG, CH Capsules Malaysia SDN BHD, Capsugel, Capsugel (Thailand) Co. Ltd, Capsugel Australia Pty Ltd, Capsugel Belgium NV, Capsugel Brasil Importação e Distribuição de Insumos Farmacêuticos e Alimentos Ltda., Capsugel Canada Corp., Capsugel Distribucion S. de R.L. de C.V., Capsugel FinanceCo II S.à r.l., Capsugel FinanceCo S.C.A., Capsugel FinanceCo S.à r.l, Capsugel France Holdings SAS, Capsugel France SAS, Capsugel Funding LLC, Capsugel Germany GmbH, Capsugel Healthcare Private Limited, Capsugel Holdings (Hong Kong) Limited, Capsugel Holdings S.à r.l., Capsugel Holdings US Inc., Capsugel Hungary Kft, Capsugel Inc., Capsugel Italy S.R.L., Capsugel Japan Inc., Capsugel Manufacturing Inc., Capsugel Middle East Sàrl, Capsugel New Zealand Limited, Capsugel Pharmaceutical and Health Products Marketing Ltd, Capsugel Philippines Inc., Capsugel Ploermel SAS, Capsugel S.à r.l., Capsugel Spain S.L., Capsugel US LLC, Capsugel de México S. de R.L. de C.V., Diacon Technologies, Diacon Technologies Limited, Hickson Ltd, InterHealth Nutraceuticals, InterHealth Nutraceuticals Incorporated, LLC Capsugel, Lonza (China) Investments Co. Ltd., Lonza AG, Lonza America Inc., Lonza Argentina S.A, Lonza Biologics Inc., Lonza Biologics Porriño S.L., Lonza Biologics Tuas Pte. Ltd, Lonza Biologics plc, Lonza Bioscience SARL, Lonza Bioscience Singapore Pte Ltd, Lonza Biotec s.r.o., Lonza Cologne GmbH, Lonza Colombia S.A.S, Lonza Copenhagen ApS, Lonza Costa Rica S.A., Lonza Geleen B.V., Lonza Guangzhou Ltd, Lonza Guangzhou Nansha Ltd, Lonza Houston Inc., Lonza Inc., Lonza India Private Limited, Lonza Israel Ltd, Lonza Japan Ltd, Lonza Luxembourg S.à r.l., Lonza Microbial Control Asia Pacific Pte Ltd, Lonza Milano S.r.l., Lonza NZ Limited, Lonza Nanjing Ltd, Lonza Netherlands B.V, Lonza Rockland Inc., Lonza Sales AG, Lonza Shanghai International Trading Ltd, Lonza Suzhou Ltd, Lonza Swiss Finanz AG, Lonza Swiss Licences AG, Lonza Verviers SPRL, Lonza Walkersville Inc., Lonza do Brasil Especialidades Quimicas Ltda., MW Encap (Holdings) Limited, MW Encap Limited, Micro-Macinazione, Micro-Macinazione SA, Octane Biotech, Octane Biotech Inc, P.T. Capsugel Indonesia, PharmaCell, Powdersize LLC, Suzhou Capsugel Limited (JV), Triangle Research Labs, Xcelience Clinical Services Ltd, Xcelience LLC, and Zelam Holdings.

When was Lonza Group founded?

Lonza Group was founded in 1897.

What is Lonza Group's official website?

The official website for Lonza Group is www.lonza.com.

Where are Lonza Group's headquarters?

Lonza Group is headquartered at Muenchensteinerstrasse 38, Basel V8, 4002.

How can I contact Lonza Group?

Lonza Group's mailing address is Muenchensteinerstrasse 38, Basel V8, 4002. The company can be reached via phone at 41-61-316-8111 or via email at [email protected]


This page was last updated on 4/17/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.